Jingyou Yu

Jingyou Yu

Harvard University

H-index: 36

North America-United States

About Jingyou Yu

Jingyou Yu, With an exceptional h-index of 36 and a recent h-index of 35 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Virology, Immunology, Vaccine research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG. 5.1 and BA. 2.86

Heterogeneous hybrid immunity against Omicron variant JN. 1 at 11 months following breakthrough infection

Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses

Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model

Ad26. COV2. S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA. 5 challenge in macaques

Booster with Ad26. COV2. S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques

Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques

Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

Jingyou Yu Information

University

Position

Beth Israel Deaconess Medical Center-Harvard Medical School

Citations(all)

9954

Citations(since 2020)

9791

Cited By

2344

hIndex(all)

36

hIndex(since 2020)

35

i10Index(all)

62

i10Index(since 2020)

61

Email

University Profile Page

Google Scholar

Jingyou Yu Skills & Research Interests

Virology

Immunology

Vaccine research

Top articles of Jingyou Yu

Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG. 5.1 and BA. 2.86

Journal of medical virology

2024/3

Heterogeneous hybrid immunity against Omicron variant JN. 1 at 11 months following breakthrough infection

bioRxiv

2024

Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses

Viruses

2023/12/9

Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model

Iscience

2023/6/16

Ad26. COV2. S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA. 5 challenge in macaques

Cell Reports Medicine

2023/4/18

Booster with Ad26. COV2. S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques

Nature Communications

2023/4/7

Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques

npj Vaccines

2023/2/23

Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

npj Vaccines

2023/2/14

Durability of heterologous and homologous COVID-19 vaccine boosts

JAMA Network Open

2022/8/1

A homologous or variant booster vaccine after Ad26. COV2. S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques

Science Translational Medicine

2022/2/22

Fighting fire with fire: Immunogenicity of viral vectored vaccines against COVID-19

2022/2/12

Aiquan Chang
Aiquan Chang

H-Index: 1

Jingyou Yu
Jingyou Yu

H-Index: 17

mRNA vaccines induce rapid antibody responses in mice

npj Vaccines

2022/8/1

Jingyou Yu
Jingyou Yu

H-Index: 17

Xiaowen Liu
Xiaowen Liu

H-Index: 20

Protective efficacy of gastrointestinal SARS-CoV-2 delivery against intranasal and intratracheal SARS-CoV-2 challenge in rhesus macaques

Journal of virology

2022/1/26

Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity

Science translational medicine

2022/7/20

A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques

Science Translational Medicine

2022/7/12

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

Nature

2022/1/20

Neutralization Escape by the SARS-CoV-2 Omicron Variants BA. 2.12. 1 and BA. 4/BA. 5

2022

Passive transfer of Ad26. COV2. S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters

npj Vaccines

2022/1/10

Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessments

Veterinary Pathology

2022/7

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26. CoV2. S vaccine study in nonhuman primates

PLoS Biology

2022/5/5

Jingyou Yu
Jingyou Yu

H-Index: 17

Hanne Andersen
Hanne Andersen

H-Index: 14

See List of Professors in Jingyou Yu University(Harvard University)